发明名称
摘要 <p>Provided is a pharmaceutical composition that contains a 1,2-dithiolthionederivative, and is effective to prevent and treat a disease caused by overactivity of a liver X receptor&alpha; (LXR&alpha;) or a sterol response element binding protein (SREBP-1). Specifically, the pharmaceutical composition includes 1,2-dithiolthione derivatives such as 4-methyl-5-(2-pyrazinyl)-1,2-dithiol-3-thione, 3-methyl-1,2-dithiol-3-thione, or 5-(6-methoxypyrazinyl)-4-methyl-1,2-dithiol-3-thione. The pharmaceutical composition is effective for preventing and treating hypertension caused by renin, aldosteronism, adrenoleukodystrophy, glomerulosclerosis, proteinuria, nephropathy, liver steatosis, hypertriglyceridemia or hyperreninemia.</p>
申请公布号 JP5300979(B2) 申请公布日期 2013.09.25
申请号 JP20110520000 申请日期 2009.07.30
申请人 发明人
分类号 A61K31/385;A61K31/41;A61K31/4436;A61K31/497;A61P1/16;A61P3/00;A61P3/06;A61P9/12;A61P13/00;A61P13/12;A61P43/00 主分类号 A61K31/385
代理机构 代理人
主权项
地址